The Board has determined that the February 2024 decision by the AOJ was legally inadequate due to a pre-decisional duty-to-assist error. The case is being remanded for further review and consideration of all relevant evidence, including medical opinions from the CEAT.
The deciding factor: The February 2024 CEAT decision did not account for all potentially favorable evidence of record regarding the Veteran's need for personal care services due to his service-connected T-cell lymphoma.
- Claimed conditions
- T-cell lymphoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- January 30, 2026
- Citation
- A26008987
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A26008987.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for T-cell lymphoma was granted on a presumptive basis pursuant to the PACT Act, effective August 10, 2022. The earlier effective date is denied.,SMC based on housebound status was granted effective August 10, 2022, and an earlier effective date is not warranted.
- Denied
The Board denied the motion to revise or reverse a previous rating decision, finding that it was not clear and unmistakable error (CUE) for the April 2002 decision not to grant service connection for T-cell lymphoma from September 1996. The Veteran's earlier claim of peripheral neuropathy did not reasonably encompass T-cell lymphoma.
- Denied
The Board denied service connection for the cause of the Veteran's death, as there was no evidence that the Veteran was exposed to herbicide agents during his service or that his T-cell lymphoma, DM, and hypertension were caused by any incident of service.
- Remanded (sent back)
The Board has remanded the cases for additional development due to potential service connection for thyroid disability and T-cell lymphoma related to exposure during military deployments in Saudi Arabia, Kuwait, and Iraq.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.